Interleukin-1β and phenytoin reduce α1 (I) procollagen mRNA expression in human gingival fibroblasts

Journal of Periodontal Research

Volumn 31, Issue 8, 1996, Pages 563-569

  Modeer T ^a,b   Anduren I ^a   Bengtsson, A ^a   Andersson, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Gingival fibroblasts; Interteukm 1 ; Phenytoin; Procollagen I

Indexed keywords

ANTICONVULSIVE AGENT; INDOMETACIN; INTERLEUKIN 1; MESSENGER RNA; PHENYTOIN; PROCOLLAGEN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHILD; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; GINGIVA; HUMAN; METABOLISM; NORTHERN BLOTTING; NUCLEIC ACID HYBRIDIZATION;

ANTICONVULSANTS; BLOTTING, NORTHERN; CELLS, CULTURED; CHILD; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION REGULATION; GINGIVA; HUMANS; INDOMETHACIN; INTERLEUKIN-1; NUCLEIC ACID HYBRIDIZATION; PHENYTOIN; PROCOLLAGEN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER;

EID: 0030277442     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1996.tb00521.x     Document Type: Article

References (38)

1. Angelopoulos AP, Goaz PW. Incidence of diphenylhydantoin gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1972; 34: 898-906.
2. Hassell TM. Phenytoin: gingival overgrowth. In: Hassell TM, ed. Epilepsy and the oral manifestations of phenytoin therapy. Basel: Karger, 1981; 116-205.
3. Modéer T, Dahllöf G, Theorell K. Oral health in non-institutionalized epileptic children with special reference to phenytoin medication. Commun Dent Oral Epidemiol 1986; 14: 165-168.
4. Kantor ML, Hassell TM. Increased accumulation of sulfated glycosaminoglycans in cultures of human fibroblasts from phenytoin-induced gingival overgrowth. J Dent Res 1983; 62: 383-387.
5. Dahllöf G, Reinholt FP, Hjerpe A, Modéer T. A quantitative analysis of connective tissue component in phenytoin-induced gingival overgrowth in children. A stereological study. J Periodont Res 1984; 19: 401-407.
6. Dahllöf G, Modéer T, Reinholt FP, Wikström B, Hjerpe A. Proteoglycans and glycosaminoglycans in phenytoin-induced gingival overgrowth. J Periodont Res 1986; 21: 13-21.
7. Nuki K, Cooper SH. The role of inflammation in the pathogenesis of gingival enlargement during the administration of diphenylhydantoin sodium in cats. J Periodont Res 1972; 7: 102-110.
8. Dahllöf G, Modéer T, Otteskog P, Sundqvist KG. Subpopulation of lymphocytes in connective tissue from phenytoin-induced gingival overgrowth. Scand J Dent Res 1985; 93: 507-512.
9. Dinarello CA. Biology of Interleukin-1. FASEB J 1988; 2: 108-115.
10. Smith JA, Mizel SB, Cohen D, Gree IRA. Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol 1982; 128: 2177-2182.
11. Mitzel SB, Dayer JM, Krane SM, Mergenhagen SE. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (Interleukin-1). Proc Natl Accad Sci 1981; 78: 2474-2477.
12. Akahoshi T, Oppenheim JJ, Matsushima K. Interleukin 1 stimulates its own receptor expression on human fibroblasts through the endogenous production of prostaglandin(s). J Clin Invest 1988; 82: 1219-1224.
13. Richards D, Rutherford RB. The effects of interleukin 1 on collagenolytic activity and prostaglandin-E secretion by human periodontal-ligament and gingival fibroblasts. Archs Oral Biol 1988; 33: 237-243.
14. Gowen M, Mundy GR. Actions of recombinant interleukin-1, interleukin-2, and interferon-γ on bone resorption in vitro. J Immunol 1986; 136: 2478-2482.
15. Lerner UH, Ljunggren Ö, Dewhirst FE, Boraschi O. Comparison of human interleukin-1β and its 163-171 peptide in bone resorption and the immune response. Cytokine 1991; 3: 141-148.
16. Modéer T, Brunius G, Iinuma M, Lerner UH. Phenytoin potentiates interleukin-1 induced prostaglandin biosynthesis in human gingival fibroblasts. Br J Pharmacol 1992; 106: 574-578.
17. Modéer T, Andurén I, Lerner UH. Enhanced prostaglandin biosynthesis in human gingival fibroblasts isolated from patients treated with phenytoin. J Oral Pathol Med 1992; 21: 251-255.
18. Postlethwaite AE, Raghow R, Stricklin GP, Poppleton H, Seyer JM, Kang AH. Modulation of fibroblast functions by interleukin 1: increased steady state accumulation of type 1 procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1α and β. J Cell Biol 1988; 106: 311-18.
19. Goldring MB, Krane SM. Modulation by recombinant interleukin-1 of synthesis of types I and II collagens and associated procollagen mRNA levels in cultured human cells. J Biol Chem 1987; 262: 16724-16729.
20. Bhatnager R, Penfornis H, Mauviel A, Loyan G, Saklatvala J, Pujol JP. Interleukin 1 inhibits the synthesis of collagen by fibroblasts. Biochem Int 1986; 13: 709-720.
21. 2. J Biol Chem 1993; 268: 10364-10371.
22. Mauviel A, Heino J, Kähäri VM, et al. Comparative effects of interleukin 1 and tumour necrosis factor α on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol 1991; 96: 243-249.
23. Ohshima M, Otsuka K, Suzuki K. Interleukin-1β stimulates collagenase production by cultured human periodontal ligament fibroblasts. J Periodont Res 1994; 29: 421-429.
24. Vernillo AT, Schwartz WB. Stimulation of collagen and glycosaminoglycan production by phenytoin (5,5′-diphe-nylhydantoin in monolayer cultures of mesenchymal cells derived from embryonic chick sternae. Arch Oral Biol 1986; 31: 819-823.
25. Salo T, Oikarinen KS, Oikarinen AI. Effect of phenytoin and nifedipine on collagen gene expression in human gingival fibroblasts. J Oral Pathol Med 1990; 19: 404-407.
26. Goultschin J, Shoshan S. Inhibition of collagen breakdown by diphenylhydantoin. Biochem Biophys Acta 1980; 631: 188-191.
27. Vernillo AT, Schwarts NB. The effects of phenytoin (5,5′-diphenylhydantoin) on human gingival fibroblasts in culture. J Periodont Res 1987; 22: 307-312.
28. Modéer T, Dahllöf G, Otteskog P. The effect of the phenytoin metabolite p-HPPH on proliferation of gingival fibroblasts in vitro. Acta Odontol Scand 1982; 40: 353-357.
29. Gustafson GT, Ljunggren Ö, Boonekamp P, Lerner. Stimulation of bone resorption in cultured mouse calvaria by Lys-bradykinin (kallidin), a potential mediator of bone resorption linking anaphylaxis processes to rarefying osteitis. Bone Miner 1986; 1: 267-277.
30. Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay for the carboxyterminal propeptide of human type 1 collagen. Clin Chem 1990; 36: 1328-1332.
31. Mäkelä JK, Raassina M, Virla A, Vuorio E. Human proalpha 1(I) collagen: cDNA sequence for the C-propeptide domain. Nucleic Acids Res 1988; 16: 349.
32. Chomzcynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
33. 2 and indomethacin. Collagen Rel Res 1985; 5: 99-118.
34. Kähäri VM, Heino J, Vuorio E. Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochim Biophys Acta 1987; 929: 142-47.
35. 2 inhibits α1(I) procollagen gene transcription and promotor activity in immortalized rat osteoblastic clonal cell line Py1a. Molecular Endocrinology 1993; 7: 17-22.
36. Sibley DR, Benovic JL, Caron MG, Lefcowitz RJ. Regulation of transmembrane signaling by receptor phosphorylation. Cell 1987; 48: 913-22.
37. Bartold PM. The effect of interleukin β on hyaluronic acid synthesized by adult human gingival fibroblasts in vitro. J Periodont Res 1988; 23: 139-147.
38. Richards D, Rutherford RB. Interleukin-1 regulation of procollagenase mRNA and protein in periodontal fibroblasts in vitro. J Periodont Res 1990; 25: 222-229.